Antiverse is building a computational antibody drug discovery platform. It combines machine learning and phage display techniques to model antibody-antigen interactions.
Vishal Singh
|
March 1, 2023
Hamburg-based Evotec, a life sciences company, announced on Friday, February 10, that it has raised an unsecured loan ...
Editorial team
February 13, 2023
Amsterdam-based Carbon Equity, a climate venture capital and private equity investment platform, announced on Wednesday the launch of ...
February 8, 2023
ExeVir Bio is a clinical stage biotechnology company developing nanobody based therapeutics focusing on infectious diseases.
January 9, 2023
Today, we bring you a list of Dutch-based biotech and life sciences startups that are changing the healthcare landscape and have raised funding in 2022.
December 30, 2022
Anocca aims to develop a technological platform for studying T-cell biology in order to realise the therapeutic potential of T-cell immunity.
December 22, 2022
EnginZyme wants to play a key role in tackling climate change by enabling green chemistry for every industry.
December 20, 2022
London-based Bactobio, a biotechnology company, announced on Monday that it has secured £6M (approximately €6.9M) in an oversubscribed ...
December 5, 2022
In recent months, the once secure and high-paying tech industry has left thousands of employees jobless. What started ...
December 2, 2022
All of Neogene Therapeutics’ outstanding shares will be acquired by AstraZeneca for up to $320M in total consideration, all of which will be paid in cash.
Bayern-based CatalYm, a biotechnology company developing immunotherapies for cancer patients, announced on Tuesday, November 22, that it has ...
November 24, 2022
In recent years, Europe has seen a boom in biotech startups. These startups are helping to drive innovation ...
October 24, 2022
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
From telecom veteran to Dutch Startup Visa success: The Jignesh Dave story